Alcohol and Substance Abuse Flashcards

1
Q

Definition of psychoactive substance, harmful use and hazardous use

A

Psychoactive substance: has effect on CNS

Harmful use: CAUSE adverse consequences, without dependence e.g. health, safety, interpersonal relationships

Hazardous use: place user AT RISK OF adverse consequences, without dependence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hx taking

A

All substances used
Pattern of use - frequency, dosage, typical day (stereotyped pattern? 規律), daily consumption
Route of access
When, why

Features of dependence

Related physical (GI, Neurocognitive) and social disability (work, finance, housing, accidents, crime, marital)
Related neuropsychiatric disorders
Past history of psychiatric illness/substance misuse
FHx

CAGE questionnaire for alcohol
- any need to Cut down, ever had people Annoyed and criticise about drinking, ever felt Guilty, need Eye-opener?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Physical examination for alcohol/substance

A
  • nutritional status
  • evidence of acute use or intoxication e.g. pupil constriction in opiate use, incoordination/slurred speech in alcohol use
  • signs of withdrawal e.g. tremor, sweating, n/v, tachycardia, pupil dilation
  • short term complications e.g. head injury, infection by IVDA
  • long term complications e.g. CLD, HBV/HCV/HIV in IVDA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Investigations for alcohol/substance

A
Urine or saliva drug screening
CBC - MCV
U&E
LFT - GGT, AST, ALT
Clotting - prolonged PT in liver damage
ECG
HBV/HCV/HIV if IVDA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aetiology of alcohol related disorders - biology, psychological, presence of other illnesses, social and environmental

A

Biological

  • strong genetic component
  • deficiency in aldehyde dehydrogenase (50% East Asians) = reduced alcohol consumption and dependence
  • chronic alcohol consumption = decrease GABA activity and increase glutamate –> increase neuroexcitability on intoxication and withdrawal seizures on cessation

Psychological

  • positive reinforcement: pleasant effects of alcohol consumption
  • negative reinforcement: negative effects of withdrawal
  • modelling (relatives and peers)

Presence of psychiatric or physical illness increases risk of alcohol abuse and dependence

  • self-medication
  • coping mech
  • impulsivity, lack of insight into risks, lack of support

Social and environmental

  • cultural attitude
  • association of certain occupations with death from alcoholic liver disease e.g. leisure, catering, doctors, journalists
  • frequent significant life events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Harmful use of alcohol - safe limits, complications of excessive use

A

Safe limits

  • men: 3-4 units/day (<21/wk)
  • women: 2-3 units/day (<14/wk)

(1 small glass of wine = 1 unit; 1 can of beer = 1.5 units; 1 catty of Chinese wine = 16 units; 1 bottle of brandy = 30 units) - vol in L x % alcohol = units

[alcohol can protect from CHD in men >40 and postmenopausal women; max 1-2 units/day]

Complications of excessive alcohol use

  • psychological: self-harm
  • social: absenteeism, legal problems/violence, interpersonal problems
  • physical:
  • -> delirium tremens, seizures, wernicke-korsakoff, cerebellar degeneration, haemorrhagic stroke
  • -> alcoholic liver disease, pancreatitis, peptic ulceration, cancers
  • -> HT, IHD, arrhythmias
  • -> hypoBG, hyperTG, hyperUr, hypoMg, hypoPO4, hypoNa, pseudo-Cushing’s
  • -> macrocytosis, anaemia, neutropenia
  • -> osteoporosis, myopathy
  • -> fetal alcohol syndrome, intrauterine growth retardation, impotence
  • -> increased trauma risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alcohol Use Disorder (alcohol dependence syndrome)

A

AT LEAST TWO of the following, in a 12 MONTH PERIOD:

  • alcohol taken in larger amounts or over a longer period than intended
  • persistent desire or unsuccessful efforts to cut down or control use (have they tried? result? why fail?)
  • craving (compelled to drink) 心癮
  • failure in fulfilling major role obligations at work/school/home
  • continued use despite having persistent social or interpersonal problems
  • primacy – important activities are given up or reduced because of alcohol use (家庭,工作,興趣,飲酒 - which is most important)
  • recurrent use in physically hazardous situations e.g. driving
  • continued use despite having knowledge of having persistent or recurrent physical or psychological problem
  • tolerance
  • -> need for increased amounts to achieve desired effect or diminished effect with use of same amount
  • withdrawal
  • -> characteristic symptoms e.g. sweating, palpitations, tremor, n/v or respite drinking (take to relieve/avoid symptoms)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epidemiology and Aetiology of AUD

A

Male 3%, Female 0.4%
(middle aged, unemployed, chronic drinking)

Aetiology

  • neurochemical basis for dependence: ethanol increases fluidity of membrane lipid, hence later varies receptors’ function
  • -> anxiolytic - increase Cl- flux effect of GABA on GABA receptor
  • -> stimulant - increase release of DA in forebrain projections to nucleus accumbens (via opioid release)
  • -> anaesthetic - inhibitory action on NMDA receptors for glutamate

Genetics

  • 60%
  • polymorphism of ADH and ALDH has protective effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CAGE questionnaire for alcoholism sensitivity and specificity

A

Sensitivity 39-83%

Specificity 92-96% (score>2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management of AUD - what to rule out, controlled drinking vs abstinence, pharmacological Tx

A
  1. RULE OUT COMPLICATIONS and treat comorbidities
    - LFT, injury, anaemia, ulcer
    - drug abuse, depression
  2. Controlled drinking vs abstinence
    - controversial evidence of efficacy
    - no more than 2 (1) drinks per day
    - NOT SUITABLE FOR CLEARLY DEPENDENT PATIENTS (chronic drinker with complications, failure to abstain – likely to relapse once taste alcohol)
    - suitable for patients with good social support
  3. Detoxification
    - done inpatient if there are risks of failing/past complications/co-morbidities
    - LONG ACTING BZD e.g. Diazepam (valium) to substitute alcohol with CNS suppression
    - Gradual TAPERING DOSE OVER A WEEK (consume liquid, oral vitamins)
    - relieve severe symptoms and reduce risk of developing withdrawal seizures or DT
  4. Thiamine, parenterally or orally
    - easy deficiency in alcoholics due to interrupted absorption in small intestine
    - to prevent Wernicke-Korsakoff syndrome
    - IV for immediate cases (prevent wernicke encephalopathy)
    - +2 yrs oral for Korsakoff syndrome
  5. Disulfuram or Naltrexone (MAINTENANCE therapy)
    - disulfuram suppresses aldehyde dehydrogenase to increase aldehyde and vasodilation/flushing/palpitations/headache/nausea after drinking (taken orally, need supervision)
    - Naltrexone - opioid antagonist to prevent relapse by decreasing DA effect in stimulant pathway to reduce craving for alcohol and reduce pleasant effect
    - -> >3-4 months treatment, check liver enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management of AUD - non-pharmacological

A

Also for maintenance

Psychotherapies

  • CBT (set goals, alternative response to triggers, interpersonal/social problems, behavioural contracting, relapse prevention)
  • Self-help groups
  • motivational interviewing to assess stage of change

Psychoeducation, skill development

Social support: social workers, probation officers

Others

  • avoid high risk settings or old acquaintances
  • set limits
  • self-monitoring e.g. diary
  • reward systems
  • rate control (spacing out drinks)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AUD prognosis and prognostic factors

A

Poor prognosis

  • 71% not in remission after 1 yr
  • 66% not in remission after 5 yrs

Prognostic factors:

  • severity, duration
  • low IQ, impaired cognition
  • personality
  • social stability
  • motivation
  • comorbid mental disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alcohol intoxication - risks, criteria

A

Potentially life threatening due to risk of respiratory depression, aspiration of vomit, hypoBG, hypothermia and trauma

  1. Recent ingestion
  2. Problematic behavioural/psychological changes e.g. aggression, mood lability, impaired judgement
  3. > 1 of the following:
    - slurred speech
    - incoordination
    - unsteady gait
    - nystagmus
    - impairment of attention or memory
    - stupor or coma
  4. Not attributable to another medical condition and not better explained by another mental disorder (including other substances)
  • -> may have anterograde amnesia (blackouts)
  • -> idiosyncratic intoxication - very rare, senseless violent behaviour after small amount of alcohol, prolonged terminal sleep, total or partial amnesia about event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alcohol withdrawal criteria and possible consequences

A

ALL states are potentially life threatening due to association with autonomic hyperactivity - MUST COVER WITH DIAZEPAM

  1. Cessation in alcohol use that has been heavy and prolonged
  2. > 2 of the following developing within several hrs-days:
    - autonomic hyperactivity e.g. sweating, palpitations
    - tremor
    - insomnia
    - nausea, vomiting
    - transient hallucinations
    - psychomotor agitation
    - anxiety
    - generalised tonic clonic seizure
  3. Causes clinically significant distress or impairment
  4. Not due to another medical condition or another mental disorder (including other substances)

Possible consequences:

  • uncomplicated withdrawal
  • perceptual disturbances
  • withdrawal seizures
  • delirium tremens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Uncomplicated alcohol withdrawal syndrome - severity, onset, symptoms, Tx

A

Mild
4-12 hrs after cessation

Tremor, sweating, n/v
Mood disturbance - anxiety, depression
Hyperacusis
Autonomic hyperactivity - tachycardia, HT, mydriasis, pyrexia
Sleep disturbance
Psychomotor agitation

Tx: BZD (long acting) - give loading dose then reassess Q1H vitals
- prevent seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alcohol withdrawal with perceptual disturbances and withdrawal seizures - onset, symptoms, Tx

A

Perceptual disturbances

  • illusions or hallucinations (TYPICALLY VISUAL)
  • delusions secondary to hallucinations

Tx: Haloperidol (also sedative)

Withdrawal seizures (“rum fit seizures”)

  • 6-48 hrs after cessation
  • 5-15% patients
  • generalised tonic clonic
  • can be life threatening and occur without any other symptoms
  • predisposing: previous Hx, concurrent epilepsy, hypoK or Mg

Tx: phenytoin for seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Delirium Tremens - severity, onset, symptoms, course, mortality, ddx

A

SEVERE
1-7 days after cessation

Altered consciousness and marked cognitive impairment (disorientation, confusion, agitation, inattention etc.) - fluctuating
Vivid hallucinations and illusions
Marked tremor
Autonomic arousal (heavy sweating, raised BP/HR, fever)
Paranoid delusions

Course:
2-4 days if untreated
5-15% mortality from CVS collapse, hypo/hyperthermia, infection

Predisposing factors: physical illness
5-20% patients undergoing detox

Ddx: other causes of delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Management of Delirium Tremens - environment, medications, monitoring

A

Emergency hospitalisation

Environment - well lighted, quiet room
Search for MEDICAL COMPLICATIONS e.g. infection, head injury, liver failure, GI haemorrhage, Wernicke’s encephalopathy –> ADMIT TO MEDICAL if any
Hydration
Medication
- HIGH DOSE BZD e.g. DIAZEPAM
- antipsychotics e.g. HALOPERIDOL for severe psychosis
- HIGH DOSE PARENTERAL THIAMINE (not oral in DT)

Monitoring –> alcohol withdrawal chart

  • temperature – hyperthermia
  • fluid – dehydration
  • electrolytes – hypoMg, hypoK
  • glucose – hypoBG

(other general measures for delirium refer to other deck)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Alcohol-related cognitive disorders (3)

A

Wernicke Korsakoff Syndrome
- THIAMINE DEFICIENCY

Wernicke’s encephalopathy
- acute brain damage with haemorrhagic lesions in grey matter around 3rd and 4th ventricles
- ATAXIA, OPTHALMOPLEGIA, DELIRIUM
–> nystagmus, 6th nerve palsy
Prognosis – 25% recover completely, 10-20% die, 84% of survivors develop Korsakoff’s syndrome

Korsakoff’s syndrome
- chronic state after Wernicke’s
- EXTENSIVE ANTEROGRADE AND RETROGRADE AMNESIA, frontal lobe dysfunction and PSYCHOTIC SYMPTOMS in absence of delirium
- further causes AMNESIC SYNDROME –> impaired recent memory, disorientation, confabulation with other cognition preserved
Tx: PARENTERAL THIAMINE

Alcoholic dementia

  • 10% of all dementia in HK community
  • long term misuse leads to impairment of memory, learning, visuospatial skills, impulse control with cortical atrophy and ventricular enlargement
  • abstinence leads to some improvement
20
Q

Alcohol-related psychotic disorders - associated delusions, severity, difference from intoxication/withdrawal, alcoholic hallucinosis vs schizophrenia, prognosis

A

Bi-directional: hallucinations and delusions can occur in heavy alcohol consumption — common comorbidity of psychotic disorders is alcohol misuse

Alcohol strongly a/w overvalued ideas or delusions of infidelity
Can be fleeting disturbances with retained insight or more persistent AH/VH or persecutory/grandiose delusions

ABSENCE OF COGNITIVE IMPAIRMENT – different from acute intoxication or withdrawal

Alcoholic hallucinosis vs Schizophrenia
- >40 vs <40
- acute vs insidious
- 3 months vs chronic
- +ve drinking hx vs not significant
- delusions secondary to hallucinations vs any delusion
- no thought disorder vs formal thought disorder
- appropriate affect vs blunted, incongruent affect
- FHx of alcoholism vs schizophrenia
(AH most common for both)

Prognosis of alcoholic hallucinosis

  • 73% duration <3 months, 14% >1 yr
  • 16% relapse
  • 9% revise Dx to schizophrenia
21
Q

Alcohol-related mood disorder - depression, mania, suicide

A

Low mood and alcohol consumption cause each other

  • social damage of alcohol on personal lives
  • difficult to differentiate alcohol-induced and true MDD

Mania can also cause problematic drinking (disinhibition)
- excessive alcohol a/w relapse of manic illness in BAD

Alcohol and suicide

  • impairs judgement and cause impulsivity –> NEED RISK ASSESSMENT
  • 16-29% lifetime risk for suicide, 7% completed suicide
  • present in 27-54% suicide attempts and 15-56% completed
22
Q

Alcohol-related anxiety disorder

A

Anxiety and alcohol consumption cause each other

Anxiolytic properties of alcohol often results in attempts of self-medication in patients with PHOBIA

Alcohol withdrawal can mimic anxiety and panic symptoms

23
Q

Substance-related disorders - psychostimulants and CNS depressants, Chinese names

A

Psychostimulant e.g. cocaine, methamphetamine, MDMA, ephedrine in cough medicine

CNS depressant e.g. BZD, Z drugs, alcohol, opioids

Methamphetamine 冰
Heroin 白粉
Midazolam 藍精靈
Methadone 美 za don
Hypnotics 安眠藥
MDMA fing 頭
Cannabis 草,大麻
Cocaine 可樂
Zoplicone 白瓜子
Ketamine K仔
24
Q

Psychostimulants and their effects (psychological and physical)

A

Alertness, hyperactivity, euphoria, irritability, aggression, hallucinations (especially cocaine – formication), psychosis

Physical effects: HT, tachycardia, arrhythmia, tremor, sweating, dilated pupil (mydriasis)

  • perforated nasal septum (cocaine)
  • fever (ecstasy)
25
Q

CNS depressants and their effects (psychological and physical)

A

Opiates e.g. heroin, methadone

  • euphoria, drowsiness, apathy
  • physical effects: miosis, conjunctival injection (hyperaemia), nausea, pruritus, constipation

Sedatives e.g BZD

  • drowsiness, disinhibition, confusion, poor concentration, reduced anxiety, feeling of well-being
  • physical effects: miosis, hypotension, withdrawal seizures, respiratory depression, impaired coordination
26
Q

Hallucinogens, Dissociative anaesthetics examples and effects

A

Hallucinogens e.g. LSD

  • marked perceptual disturbances with chronic flashbacks, paranoid ideas, psychosis, suicidal ideas
  • physical: mydriasis, conjunctival injection, HT, tachycardia, sweating, fever, tremors, LOA

Dissociative anaesthetics e.g. Ketamine

  • hallucinations, paranoid ideas, thought disorganisation, aggression
  • physical: mydriasis, tachycardia, HT, perforated nasal septum
27
Q

Cannabinoids effects

A

Euphoria, relaxation, ALTERED TIME PERCEPTION, psychosis

Impaired coordination and reactive time, conjunctival injection, nystagmus, dry mouth

28
Q

Inhalants examples and effects

A

Aerosols, glue, light fluid, petrol

Disinhibition, stimulation, euphoria, clouded consciousness, hallucinations, psychosis

Physical: headache, nausea, slurred speech, loss of motor coordination, muscle weakness, damage to brain/BM/liver/kidneys/myocardium, sudden death

29
Q

Stimulant use disorder criteria, determining severity

A

AT LEAST TWO of the following in a 12 MONTH PERIOD
- (same as alcohol use disorder)

Mild 2-3
Moderate 4-5
Severe >6

30
Q

Aetiology of dependence syndrome - which drugs more likely, risk factors, conditioning

A

Drugs with strong potential for dependence e.g. cocaine, opiates

A/w increasing DA release from mesolimbic pathway
- operant conditioning (association of behaviour and consequence – reward or punishment)

Price, availability and cultural attitude

Risk factors:
Social deprivation, family environment, conduct disorder in childhood, antisocial personality disorder, severe mental illness

31
Q

Hx taking for substance abuse

A

Nature, extent and pattern of use

  • quantity (may ask cost if patient can’t specify), method, circumstances, form of drug, frequency
  • primary drug of abuse
  • why use?
  • recent use/last use (past use = >12 mths)
  • effects – drug induced psychosis most common

Dependence features

Complications and risk assessment
- Bio e.g. blood borne disease such as HIV/HBV for Heroin, liver/HT/pancreatitis for alcohol, **cystopathy/cholangiopathy/nasal problems for ketamine, head injury

  • Psycho e.g. stimulants (psychosis causing violent risk especially meth, depression on withdrawal with suicidal risk) vs depressants (depression, cognitive impairment with risk of self-neglect, withdrawal seizure)
  • rmb OPIOIDS WON’T HAVE SEIZURES
  • Social e.g. interpersonal, financial, vocational, legal, family, children

FHx of suicide, drug abuse, psychiatric illness

Other hx as usual
MSE – assess stage of change and motivation

32
Q

Physical examination and Ix for substance abuse

A

Signs of intoxication

Heroin –> IVDA - thrombophlebitis; pinpoint pupil

Meth –> meth bugs (due to tactile hallucination and delusion of infestation, itchiness of skin), teeth grinding, poor hygiene

Ketamine –> perforated nasal septum (ischaemic necrosis by vasoconstriction)

Cough med –> teeth cavities (sweetness, xerostomia)

Cannabis –> conjunctival injection

Ix: urine toxicology

33
Q

Management of opiate abuse - overdose, primary objective, short term approach, medications, symptoms and risk of withdrawal, psychological therapy, addressing perpetuating factors

A

If overdose: NALOXONE antidote

Primary objective: DETOX (gradual reduction of dosage, until zero)

Short term: HARM REDUCTION principle
- education on risks of contaminated equipment, unsafe sexual behaviour

SUBSTITUTION therapy

  • Methadone 老美 (long acting opiate) with gradual reduction
  • Bupropion (partial agonist) may be used but can precipitate withdrawal in high dependence

Lofexidine (alpha2A adrenergic receptor agonist) can also help with withdrawal (insomnia, muscle ache/chills, sweating, diarrhoea, vomiting, flu-like symptoms) by reducing sympathetic outflow

Remember - OPIATE WITHDRAWAL NOT LIFE THREATENING, NOT 100% HAVE TO COVER WITH DRUG

After detox, naltrexone used to block euphoriant effects of future opiate use

Psychological: motivational interviewing, CBT, group therapy

Address perpetuating factors e.g. issues with family and peers, housing, criminality, prostitution, engagement with healthcare and social services

34
Q

Management of BZD abuse - symptoms of withdrawal, risks, medications/approach

A

Benzodiazepine withdrawal syndrome
- hallucinations, convulsions, delirium, tingling, numbness, sensory hypersensitivity, muscle twitches, tinnitus, DEATH

SWITCH to LONG ACTING drugs e.g. diazepam then DOSE REDUCED VERY SLOWLY every wk depending on response – usually around 1/8 REDUCTION EVERY 14 DAYS
(shorter acting = easier seizure such as midazolam)
–> withdrawal chart to monitor

35
Q

Criteria for stimulant withdrawal

A
  1. Cessation of prolonged stimulant use
  2. DYSPHORIC mood and >2 of the following
    - fatigue
    - increased appetite
    - vivid, unpleasant dreams
    - insomnia, hypersomnia
    - psychomotor agitation or retardation
  3. Cause significant distress or impairment
  4. Not due to another medical condition or disorder
36
Q

Methamphetamine - Chinese names, type of drug, route of administration, usual dose/pattern of use, acute mental and physical effects, withdrawal symptoms, psychiatric comorbidities

A

ICE
冰,凍嘢,麻古,滑雪

Causes dopamine release
Tx of ADHD, narcolepsy but not prescribed in HK

Stimulant, usually smoked (heated and vaporised into bottle/Ice bong with juice, then inhaled)

  • 0.1-0.2g daily consumption, median 0.3
  • usually use a lot in one go then stop when euphoria decreases (11.9+/- 9.3 hrs)

Effects:

  • acute mental/intoxication - euphoria, alertness, energy, increased libido, PREOCCUPATION IN OWN THOUGHTS, psychotic symptoms at high dose
  • acute physical - HT, tachycardia, mydriasis, hyperthermia, seizures, anorexia (APPETITE SUPPRESSION), stereotypy (repeating actions), renal failure

Prolonged sleep and mild dysphoria as drug effects wear off

Withdrawal 熔雪

  • dysphoria (depressed mood, anxiety)
  • disturbed sleep
  • reduced energy
  • cognitive impairment
  • craving
  • increased appetite

Psychiatric comorbidities

  • 76% PSYCHOSIS
  • 11% mood
  • 1% anxiety
37
Q

ICE induced psychosis - common forms, duration/dose/onset, criteria for drug induced psychosis

A

Hallucinations 85% auditory, 46% visual
Delusions of reference 63%, persecutory 42%

Variability in dose required and onset of symptoms
Duration also variable

Dx of drug induced psychosis

  • delusions/hallucinations
  • related to intoxication of drug with KNOWN PSYCHOTIC EFFECTS
  • excluding other psychiatric disorders e.g. Hx of non-drug related psychosis, psychotic symptoms persisting >1 month after last drug use
  • presence of psychosis in non-delirium state

But in reality, usually patients constantly take drugs so can’t tell from underlying schizophrenia (assume organic cause in Ddx)

38
Q

Cocaine - type of drug, pattern of use/route, acute effects, long term effects, intoxication and withdrawal symptoms, psychiatric comorbidities

A

可卡因
- action similar to ICE

Stimulant, usually snorted, also smoked (crack cocaine)
Average 0.7g daily consumption
Very expensive – financial problems in patients

Effects:

  • acute mental: euphoria, arousal, focus and alertness, libido, talkative, improved fatigue and performance, LOA
  • acute physical: increased HR/BP, mydriasis, increased light sensitivity, rapid speech, dyskinesia, n/v

Long term use:

  • nasal septum perforation (ischaemic effect), damage to cribriform plate leading to loss of smell
  • rashes, skin reddening itching, picking, scratching

Intoxication: 1-2g (lethal dose)
- chest pain, sweating, tremors, confusion, hyperthermia, renal damage, seizures, stroke, arrhythmia

Withdrawal: 1-3 wks
- craving, dysphoria, depression, increased appetite, hypersomnia

Psychiatric comorbidities

  • substance induced psychosis –> 90% delusional, 83% AH, 38% VH, 21% tactile (FORMICATION)
  • MDD
  • substance induced mood disorder
  • schizophrenia
  • GAD
39
Q

Ketamine - type of drug, pattern of use/route, psychological effects, brain damage effects, physical complications, toxicity, psychiatric comorbidities, treatment

A

K仔

  • NMDA receptor blockade
  • medical use for pain control
  • common abuse in HK and China

Hallucinogen, usually snorted, 0.5-20g daily

Effects:
- acute in healthy ppl - perceptual disturbances (dissociation, delusions, hallucinations), schizophrenia-like negative symptoms/positive symptoms/cognitive symptoms (executive fx, episodic memory)

  • acute in psychiatric patients - exacerbate schizophrenia positive symptoms, impairs cognition, rapid but transient antidepressant effect

Brain damage:

  • reduced regional grey matter volume at orbitofrontal, medial prefrontal and hippocampus
  • -> affect attention, executive function, visual/verbal memory

Physical complications:

  • CYSTITIS –> dysuria, frequency, urge incontinence, urgency, painful haematuria, reduced bladder capacity
  • cholangiopathy (strictures)
  • perforated nasal septum

Toxicity: respiratory depression, coma (lethal dose unknown)

Psychiatric comorbidities
- mood, psychotic, anxiety disorders

Tx: psychosocial interventions, no specific medications, may require long term (12 months) residential tx e.g. rehab centres

40
Q

Cannabis - forms of drug, addictive content, pattern of use/route, mental and physical effects, intoxication, comorbidities, increases risk of which disease

A

MOST COMMONLY ABUSED - 30% can become addicted
草,牛,花,大麻

Forms: herbal cannabis (chopped dried leaves), resin 糕 secreted by plant (10-20% THC), hashish oil product of extraction by organic solvents (15-30% THC)

Tetrahydrocannabinol THC interacts with endogenous receptors to increase dopamine release
- not legal in HK; legal in other countries

Smoked (roll into cigarette), 0.5-6g per joint
–> can be used more regularly than ICE (establish regular, persistent or solitary use in history)

Effects:
- acute mental - relaxation, euphoria, disorientation, ALTERED PERCEPTION OF TIME AND SPACE (everything feels slower), lack of concentration, MORE VIVID SENSES (everything magnified), sedation, mood changes e.g. paranoia

  • acute physical - increased HR, conjunctival injection, dry mouth, increased appetite, vasodilation

Intoxication

  • dulling of attention
  • psychosis, image distortion

Toxicity: overdose uncommon, not fatal

Psychiatric comorbidities

  • substance induced psychosis (1/6)
  • **SCHIZOPHRENIA (most a/w with increased risk of schizo)
  • MDD
  • substance induced mood disorder
41
Q

Treatment of Cannabis use disorder - first line, other options

A

Psychosocial interventions first line
- CBT, motivational enhancement therapy, multidimensional family therapy

Medication for withdrawal symptoms (anxiety, irritability, tremors, nausea)

  • cannabinoid-1-agonists
  • zolpidem +/- nabilone
  • nabilone with lofexidine
  • nabiximols
42
Q

Cough medicine - main ingredients, effect, withdrawal, cormorbidities, overdose effects

A

3 main ingredients

  • ephedrine – vasoconstriction, decrease drowsiness
  • codeine or dextromethorphan – opioid, affect airway
  • promethazine – 1st gen antihistamine, drowsiness

Effects:

  • acute mental - euphoria, dissociation
  • acute physical - slurred speech, ataxia, nystagmus
  • chronic mental - hallucinations, manic, irritability, paranoia, disorganised behaviour
  • chronic physical - muscle aches, stomach upset/abd pain, n/v/d, night sweats, agitation

Withdrawal:
- v/d, night sweats, muscle aches, restlessness, early insomnia, feeling cold and sweaty

Psychiatric comorbidities:
- many (drug induced psychosis, MDD, dysthymia, drug induced mood disorder, GAD, schizo etc)

Overdose: lethal, drug conc of dextromethorphan 950 microgram/L

43
Q

MDMA/Ectasy - type of drug, route, effects, chronic mental effects, psychiatric comorbidities

A

Derivative of meth, potency 1/8 of meth
Stimulant and Hallucinogen

Swallowed, 1 tablet/day (70-140 mg)

Effects:

  • acute mental - relaxation, euphoria, increased energy, increase sociability, increased responsiveness to touch; agitation/panic attacks/hallucinations at high dose
  • acute physical - mydriasis, increased HR/BP, fever, increased light sensitivity, rapid speech, n/v, dyskinesia
  • chronic mental effects - poor memory recall, panic attacks, psychosis, depersonalisation

Psychiatric comorbidity
- many

44
Q

Sleeping pills - examples, Chinese names, detox regime, acute mental/physical effects, chronic mental/physical effects, psychiatric comorbidities

A

Z drugs
- zoplicone, zolpidem 瓜子

BZD
- midazolam 藍精靈, nimetazepam 花仔/五仔

Detox: Switch to LONG ACTING BZD, Q1H monitor vitals and withdrawal symptoms, taper down gradually

Acute mental effects:

  • both sedative, hypnotic, anxiolytic
  • Z drug euphoria in high dose

Acute physical effects:

  • Z drug - muscle relaxant, respiratory inhibition, psychomotor and coordination problems, danger of falls
  • BZD - muscle weakness, ataxia, confusion, headache, blurred vision, GI disturbances

Chronic mental effects:

  • tolerance/addiction, psychiatric symptoms e.g. depression, anxiety, cognition impairment, amnesia
  • Z drugs - psychosis, sleep walking, compulsive behaviour
  • BZD - confusion

Chronic physical effects:

  • renal/hepatic impairment
  • Z drugs - urinary incontinence, palpitations
  • BZD - weakness, dizziness, paraesthesia, visual disturbances, GI disturbances, flu-like symptoms

Toxicity

  • delirium, cognition impairment, shallow breathing, coma, death
  • Z drugs - psychosis

Withdrawal

  • rebound insomnia, anxiety, depression, tremor, seizures, delirium
  • Z drugs - psychotic reactions, n/v, lightheadedness
  • BZD - numbness, muscle twitching, tinnitus, hallucinations, decreased memory/attention, death!

Psychiatric comorbidities

  • MDD, substance induced psychosis
  • GAD
  • dysthymia, substance induced mood disorder
  • schizophrenia
45
Q

Stages of change to assess motivation

A
  1. Precontemplation
    - denial, ignoring problem, not considering change
  2. Contemplation
    - ambivalence, conflicting emotions (positive benefits of change vs costs of change)
    - may last a long time
  3. Preparation
    - experimenting with small changes, collecting information about change
  4. Action
    - direct action towards a goal
  5. Maintenance
    - maintenance of new behaviour and avoiding temptations
  6. Relapse
    - may feel frustrated, disappointed, failed